High-purity raw materials optimized for Spanish dietary supplement manufacturers and healthcare brands.
Spain stands as one of the key cornerstones of the European Union's pharmaceutical manufacturing network. Centered around major industrial hubs in Catalonia, Madrid, and the Basque Country, the Spanish pharmaceutical sector is experiencing rapid evolution. Local Contract Development and Manufacturing Organizations (CDMOs) and generic drug formulators are continually seeking strategic alliances with global API and chemical intermediate suppliers to stabilize supply lines, comply with EU GMP standards, and streamline lead times.
In an era characterized by stringent regulatory environments under the EMA (European Medicines Agency) and the local AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), securing reliable, high-grade active ingredients and chemical precursors is critical. Procurement directors in Spain are increasingly prioritizing partners who offer comprehensive documentation (DMF, CEP/COS, and REACH compliance) alongside structural supply resilience.
The global pharmaceutical supply chain is undergoing a structural transformation. Geopolitical shifts, combined with lessons learned from recent supply crises, have forced a move away from single-source reliance toward diversified sourcing strategies. Active Pharmaceutical Ingredients (APIs) and advanced chemical intermediates represent the most sensitive components of this ecosystem.
As EU companies optimize their research and manufacturing pipelines, they demand higher purity levels, advanced solid-state characterization (e.g., specific polymorphic forms), and robust validation data. The integration of ecological standards (Green Chemistry) in intermediate synthesis is no longer optional; it has become a standard procurement requirement to reduce the environmental footprint of finished dosage formulations (FDF).
For nearly 10 years, Serum Pharma has been dedicated to the production and export of high-purity biological products, vaccines, Western medicines, APIs, intermediates, medical consumables, food additives, and premium plant extracts. By bridging manufacturing efficiencies in China with strict regulatory oversight, we provide Spanish and European buyers with a robust, reliable, and cost-effective raw material gateway.
Download Corporate BrochureThe synergy between Spanish pharmaceutical R&D capabilities and Chinese chemical manufacturing scale is a powerful driver for industry growth. China’s advanced chemical industrial parks offer unmatched supply chain integration. From basic raw materials to highly sophisticated intermediates, the localized proximity of chemical suppliers drastically reduces production costs and lead times.
At Serum Pharma, we leverage this industrial concentration to benefit our clients in Madrid, Barcelona, and Valencia. Our manufacturing sites utilize advanced automation and continuous flow chemistry to ensure batch-to-batch consistency. This technological efficiency, combined with raw material security, translates into significant cost savings that help Spanish manufacturers remain highly competitive in the global generic drug market.
Our APIs and advanced intermediates are engineered for a wide array of localized applications across the Iberian Peninsula:
Continuous monitoring of cutting-edge markets enables Serum Pharma to offer sophisticated, custom product customization services.
Customized raw material pre-mixing designed to optimize blend uniformity, reduce processing steps, and simplify manufacturing processes for finished dosage forms.
Advanced engineering of multi-component crystal structures to dramatically improve solubility, bio-availability, chemical stability, and physical properties of APIs.
Utilizing high-yield microbial strains and enzymatic synthesis platforms to produce sustainable, high-purity natural compounds and chemical intermediates.
Stay updated on global pharmaceutical supply trends, active molecule breakthroughs, and manufacturing standards.
An in-depth look at the shifting paradigm from shark-derived squalene to eco-friendly, plant-sourced alternatives. We analyze how vaccine adjuvants and cosmetic formulations are transitioning to sustainable chemistry.
As a key corticosteroid anti-inflammatory, Dexamethasone Sodium Phosphate maintains massive global clinical demand. This paper reviews quality parameters, impurity profiling, and crystallization techniques essential for FDF manufacturers.
The FDA’s rapid approval of Eli Lilly’s Foundayo™ (orforglipron) represents a tectonic shift in weight-loss medicine. As the first oral, non-peptide GLP-1 agonist with no dietary restrictions, it highlights the rising demand for sophisticated organic small-molecule intermediates.
Expert answers to common queries regarding API procurement, quality compliance, and logistical arrangements for Spain and Europe.
We work closely with manufacturers operating under strict GMP conditions. We supply comprehensive regulatory packages, including DMF (Drug Master Files), CEP/COS (Certificates of Suitability) from the EDQM, and complete REACH dossiers to satisfy AEMPS and European Medicines Agency (EMA) specifications.
Standard sea freight from our Chinese facilities to the ports of Barcelona or Valencia typically takes 30 to 35 days. For urgent pharmaceutical intermediates or clinical batches, we offer expedited air courier services delivering directly to your laboratory or manufacturing plant within 5 to 7 working days.
Yes. Our dedicated co-crystallization and solid-state research laboratories specialize in customizing polymorphic structures. We work with clients to optimize bioavailability, compressibility, and thermodynamic stability according to their drug delivery systems.
Absolutely. We supply plant proteins (such as Pea, Fava Bean, and Mung Bean proteins) and plant-derived oils in both conventional and organic versions, certified in accordance with EU organic regulations to meet the growing clean-label demand in Europe.
Every single batch undergoes rigorous quality control testing in our analytical laboratories, equipped with HPLC, GC, LC-MS, and particle size analyzers. We supply a comprehensive Certificate of Analysis (CoA) with every shipment. Third-party lab testing via accredited independent European laboratories can also be arranged upon request.
Our bio-fermentation technology replaces traditional multi-step chemical synthesis with highly efficient enzymatic pathways. This drastically reduces the consumption of organic solvents, lowers carbon emissions, minimizes toxic waste generation, and delivers high-purity biomolecules ideal for sustainable pharmaceutical manufacturing.
Explore our diverse chemical and biological catalog supporting cosmetic, pharmaceutical, and nutritional formulations across the EU.
